Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: Opella Healthcare France SAS T/A Sanofi, 82 Avenue Raspail, 94250 Gentilly, France
For the relief of the symptoms of dyspepsia.
The route of administration is oral.
One to Two x 5 ml spoonfuls taken 20 minutes to one hour after meals and at night as required or as directed by the physician.
Not recommended.
Reported symptoms of acute overdose with aluminium hydroxide and magnesium salts combination include diarrhea, abdominal pain, vomiting. Large doses of this product may trigger or aggravate intestinal obstruction and ileus in patients at risk (see Section 4.4 Special warnings and precautions for use).
Aluminium and magnesium are eliminated through urinary route; treatment of acute overdose consists of rehydration, forced diuresis. In case of renal function deficiency, haemodialysis or peritoneal dialysis is necessary.
Serious symptoms are unlikely following overdosage.
As packaged for sale: 3 years.
After first opening the container: this product should be used within 6 months of first opening the bottle.
Do not store above 25ºC.
White PET bottles with plastic screw cap: 250 ml and 355 ml.
Not all pack sizes are marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
